Vaccine made from virus like particle (VLP). VLPs contain repetitive, high density displays of viral surface proteins that present conformational viral epitopes that can elicit strong T cell and B cell immune responses. Since VLPs cannot replicate, they provide a safer alternative to attenuated viruses. Vaccines for Hepatitis B and human papillomavirus, are developed and FDA-approved.